Active-ingredient Dossier
Ferric Carboxymaltose
Active-ingredient Dossier for Ferric Carboxymaltose (iron replacement agent). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: FERINJECT
- Brand: FERIVO
- Brand: FERRIVE
- Brand: CARBOFERM
- Brand: FERRIC
- Brand: FERRIC CARBOXYMALTOSE-TEVA
- Therapeutic area: Haematology
What is
Ferric Carboxymaltose Ferric carboxymaltose is an iron replacement agent.
Australian brands containing
Ferric Carboxymaltose — FERINJECT — FERIVO — FERRIVE — CARBOFERM — FERRIC — FERRIC CARBOXYMALTOSE-TEVA — FERRICARBO
Therapeutic areas
Ferric carboxymaltose is registered in haematology, with seven brands containing the ingredient on the ARTG.
Sponsor landscape
Five sponsors market ferric carboxymaltose in Australia: Dr Reddys Laboratories, Seqirus, Sandoz, Teva Pharma, and Alphapharm.
PBS and regulatory activity
One brand containing ferric carboxymaltose is PBS-listed, with the latest PBS schedule date of 1 May 2026. In fiscal year 2024–25, PBS expenditure on ferric carboxymaltose was $147,545,299, covering 555,410 scripts. The latest PBAC outcome is dated 1 November 2018, and the latest AusPAR is dated 5 April 2011.